Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Ophthalmology. 2015 Feb 14;122(5):1008–1015. doi: 10.1016/j.ophtha.2014.12.017

Figure 1.

Figure 1

Pre- and post-treatment images of the retina after intravitreal bevacizumab. Prior to treatment, plus disease with prominent tortuosity and congestion of the retinal vessels are observed in the left eye of a patient with Type 1 ROP (A). Two weeks post-treatment, the retinal vesels appear significantly less tortuous and congested (B).